Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 3Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 7OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Dupuytren Contracture 3

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × xiapex × Clear all
NCT02647619 2022-04-26

Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF

University Hospital, Akershus

Phase 4 Completed
80 enrolled

Dupuytren Contracture

NCT03331926 2020-04-22

Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease

Horsens Hospital

Completed
199 enrolled

Dupuytren Contracture

NCT01538017 2016-10-04

Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture

Regionshospitalet Silkeborg

Phase NA Completed
50 enrolled

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon âš¡